Heterodimeric Antibodies, Uses in Therapeutic Applications, and Compositions Related Thereto

Abstract

Disclosed herein are mutant heavy chain antibody sequences. In certain embodiments, this disclosure contemplates heterodimeric antibodies with a first heavy chain and a second heavy chain, wherein the first and second heavy chain, or fragments thereof contain different mutations. In certain embodiments, this disclosure relates to nucleic acids and vectors encoding antibodies and recombinant heavy chains disclosed herein and cells containing the same.

Dependencies are inferred from the claim text.